Sensient Technologies (SXT) director acquires deferred stock via fee deferral

Rhea-AI Filing Summary

Sensient Technologies Corp. director reports deferred stock transaction

A director of Sensient Technologies Corp. (SXT) reported a routine equity-related transaction. On 12/31/2025, the director acquired 102.821 shares of deferred stock through the deferral of director fees under the company’s Directors' Deferred Compensation Plan. This deferred stock is convertible into common stock on a one-for-one basis, with shares of common stock to be issued when the director’s board service ends.

Following this transaction, the director beneficially owned 16,394.007 shares of common stock directly and 5,702.328 derivative securities in the form of deferred stock. The filing identifies the reporting person as a director and indicates the ownership is held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McKeithan Gebhardt Deborah

(Last) (First) (Middle)

777 EAST WISCONSIN AVENUE

(Street)

MILWAUKEE WI 53202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SENSIENT TECHNOLOGIES CORP [ SXT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								16,394.007(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock	(2)	12/31/2025		A(3)		102.821		(4)	(4)	Common Stock	102.821	$0	5,702.328	D

Explanation of Responses:

1. Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.

2. Deferred stock converts to common stock on a one-for-one basis.

3. Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.

4. Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.

	/s/ John J. Manning, Attorney-in-Fact for Ms. McKeithan-Gebhardt	01/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Sensient Technologies (SXT) report in this Form 4?

The filing reports that a director acquired 102.821 shares of deferred stock on 12/31/2025 through the deferral of director fees under the Directors' Deferred Compensation Plan.

How many Sensient Technologies (SXT) common shares does the director beneficially own after this transaction?

After the reported transaction, the director beneficially owned 16,394.007 shares of common stock directly.

What are the derivative securities reported by the Sensient Technologies (SXT) director?

The derivative securities consist of deferred stock that converts to common stock on a one-for-one basis, with 5,702.328 such derivative securities beneficially owned following the transaction.

When will the deferred stock for the Sensient Technologies (SXT) director be issued as common shares?

The filing states that shares of common stock will be issued upon termination of the reporting person’s service as a director of Sensient Technologies Corp.

How were the deferred stock units for the Sensient Technologies (SXT) director created?

The 102.821 deferred stock units reported on 12/31/2025 arose from the deferral of director fees under Sensient’s Directors' Deferred Compensation Plan.

Does this Sensient Technologies (SXT) Form 4 involve restricted stock or dividend reinvestment?

The explanation notes that the director’s common stock holdings include restricted stock under the Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.